TY - JOUR T1 - Decoding accelerometry for classification and prediction of critically ill patients with severe brain injury JF - medRxiv DO - 10.1101/2021.05.19.21257319 SP - 2021.05.19.21257319 AU - Shubhayu Bhattacharyay AU - John Rattray AU - Matthew Wang AU - Peter Dziedzic AU - Eusebia Calvillo AU - Han B. Kim AU - Eshan Joshi AU - Pawel Kudela AU - Ralph Etienne-Cummings AU - Robert D. Stevens Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/05/25/2021.05.19.21257319.abstract N2 - Our goal is to explore quantitative motor features in critically ill patients with severe brain injury (SBI). We hypothesized that computational decoding of these features would yield information on underlying neurological states and clinical outcomes. Using wearable microsensors placed on all extremities, we recorded 1,701 hours of continuous, high-frequency accelerometry data from a prospective cohort (n = 69) admitted to the ICU with SBI. Models were trained using time-, frequency-, and wavelet-domain features and levels of responsiveness and outcome as labels. The two primary tasks were detection of levels of responsiveness, assessed by motor sub-score of the Glasgow Coma Scale (GCSm), and prediction of functional outcome at discharge, measured with the Glasgow Outcome Scale–Extended (GOSE). Detection models achieved significant (AUC: 0.70 [95% CI: 0.53–0.85]) and consistent (observation windows: 12 min – 9 hours) discrimination of SBI patients capable of purposeful movement (GCSm > 4). Prediction models accurately discriminated SBI patients of upper moderate disability or better (GOSE > 5) with 2– 6 hours of observation (AUC: 0.82 [95% CI: 0.75–0.90]). Results suggest that computational analysis of time series motor activity in patients with SBI yields clinically important insights on underlying neurologic states and short-term clinical outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by awards from the Johns Hopkins University Office of the Provost and the Hodson Trust, received by S.B. S.B. is currently funded by a Gates Cambridge fellowship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work was conducted with approval from the Johns Hopkins Medicine Institutional Review Board (IRB00135674) and written informed consent from patients or surrogates. We prospectively enrolled 72 patients admitted to the NCCU who met the following criteria: age ≥ 18 years, SBI defined as an acute brain injury or illness resulting in impaired consciousness, absence of injuries or lesions involving the extremities, and not expected to die or have withdrawal of life-sustaining therapies in the 24 hours following enrolment.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPer our current Johns Hopkins Medicine IRB protocol (IRB00135674), we are not permitted to share the clinical data collected for this study. However, we welcome all forms of collaboration, and urge interested investigators to contact the corresponding author (SB: sb2406@cam.ac.uk) with their institutional affiliation and proposed use of the dataset to submit a new protocol for access. The data may not be used for commercial products or redistributed in any way. ER -